Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Terminated NCT07190794

RESCUE: Discontinuation of GLP-1

Conditions: Obesity

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: No

Enrollment: 18

Sponsor: Boston Scientific Corporation

Location: Bariendo Miami Florida

Summary

This study is designed to compare weight loss outcomes and safety of ESG versus lifestyle modification in patients with obesity who discontinued GLP-1 therapy due to intolerance or suboptimal weight loss.

Eligibility Criteria

Inclusion Criteria: 1. Adults (≥ 18 years) 2. BMI ≥30 kg/m² and ≤ 50 kg/m2 3. Discontinued GLP-1 therapy for weight loss (semaglutide and tirzepatide only) for intolerance or suboptimal weight loss (\

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07190794). StuddyBuddy aggregates publicly available trial information.